Post-approval studies (Phase 4)Ended earlyNCT00102947
What this trial is testing
Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections
Who this might be right for
Soft Tissue Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 72